在严重的乙酸性喘中持续性呼吸道阻塞:准介素-5和乙酸性喘
Nicola A Hanania1, Felix J F Herth2
1Section of Pulmonary, Critical Care and Sleep Medicine, Airways Clinical Research Center, Baylor College of Medicine, Houston, TX, USA hanania@bcm.edu.
概括
患有严重酸性喘和持续性呼吸道阻塞的患者可能受益于向生物治疗. 需要进一步的研究来确认这种独特的临床组的疗效和安全性.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的喘影响了许多患者,其中40-60%的人经历了持续的气道阻塞 (PAO).
- 在临床指导方针中,PAO的严重酸性喘 (SEA) 代表性不足,尽管医疗负担很大.
- 异性气道炎症驱动SEA特征,增加PAO和不可逆转的肺功能下降的风险.
研究的目的:
- 检查针对PAO患者SEA的生物治疗方法的有效性.
- 为了识别与PAO管理SEA的数据缺口.
- 为了优化这种患者亚组的管理策略.
主要方法:
- 对SEA和PAO生物治疗方法的现有临床和现实世界的数据的审查.
- 评估IL-5/Rα向生物制剂 (本拉利祖马布,梅波利祖马布) 的研究分析.
- 确定对治疗有反应的SEA和PAO患者队列.
主要成果:
- 针对IL-5/Rα的生物治疗在一些SEA和PAO患者中显示出显著的反应.
- 在SEA中PAO代表了一个独特的临床实体,可能是"持续的eosinophilic气道阻塞".
- 临床试验经常排除PAO患者,限制数据.
结论:
- 患有持续性埃索诺菲尔呼吸道阻塞的患者可能对向生物疗法反应良好.
- 需要额外的临床研究和现实世界的数据来确认疗效和安全性.
- 进一步的研究将指导临床实践来管理这种特定的喘患者群体.
相关概念视频
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K


